{"id":481573,"title":"Notice: Revisions to the performance standards for Post-authorization Division 1 Changes  - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T17:00:22.893000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-revisions-performance-standards-post-authorization-division-1-changes.html?wbdisable=true","snippet":"Notice: Revisions to the performance standards for Post-authorization Division 1 Changes August 2, 2022 Our file number: 22-107706-88 Health Canada is revising the performance standards for Post-authorization Division 1 Changes (PDCs) for prescription pharmaceutical drugs and…","rawSnapshotUrl":"/api/snapshots/raw/481573","browseUrl":"https://replay.healtharchive.ca/job-6/20260106170022/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-revisions-performance-standards-post-authorization-division-1-changes.html?wbdisable=true#ha_snapshot=481573","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}